11/21
07:25 am
sana
ATTENTION SANA SHAREHOLDERS: Investors who lost money on Sana Biotechnology, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
Medium
Report
ATTENTION SANA SHAREHOLDERS: Investors who lost money on Sana Biotechnology, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
11/20
03:15 pm
sana
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
11/20
07:30 am
sana
Shareholder Rights Advocates at Levi & Korsinsky Investigate Sana Biotechnology, Inc. (SANA) Regarding Possible Securities Fraud Violations
Medium
Report
Shareholder Rights Advocates at Levi & Korsinsky Investigate Sana Biotechnology, Inc. (SANA) Regarding Possible Securities Fraud Violations
11/19
07:30 am
sana
Did Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - SANA
Low
Report
Did Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - SANA
11/18
09:52 pm
sana
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
11/18
07:30 am
sana
Levi & Korsinsky Announces an Investigation on Behalf of Sana Biotechnology, Inc. (SANA) Shareholders Who May Have Been Affected by Fraud
Medium
Report
Levi & Korsinsky Announces an Investigation on Behalf of Sana Biotechnology, Inc. (SANA) Shareholders Who May Have Been Affected by Fraud
11/16
12:00 pm
sana
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
11/14
05:00 pm
sana
Did Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate– SANA
Medium
Report
Did Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate– SANA
11/14
04:00 pm
sana
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
11/14
07:30 am
sana
Sana Biotechnology, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - SANA
Medium
Report
Sana Biotechnology, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - SANA
11/12
03:45 pm
sana
Shareholder Rights Advocates at Levi & Korsinsky Investigate Sana Biotechnology, Inc. (SANA) Regarding Possible Securities Fraud Violations
Low
Report
Shareholder Rights Advocates at Levi & Korsinsky Investigate Sana Biotechnology, Inc. (SANA) Regarding Possible Securities Fraud Violations
11/12
02:30 pm
sana
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
11/12
07:30 am
sana
Sana Biotechnology, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- SANA
Low
Report
Sana Biotechnology, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- SANA
11/11
11:49 am
sana
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround [Yahoo! Finance]
11/11
08:10 am
sana
Sana Biotechnology, Inc. (NASDAQ: SANA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Sana Biotechnology, Inc. (NASDAQ: SANA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
11/11
07:25 am
sana
Sana Biotechnology, Inc. Being Investigated on Behalf of Sana Biotechnology, Inc. Investors. Contact Levi & Korsinsky For Details.
Medium
Report
Sana Biotechnology, Inc. Being Investigated on Behalf of Sana Biotechnology, Inc. Investors. Contact Levi & Korsinsky For Details.
11/8
09:00 am
sana
Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
Medium
Report
Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
11/7
03:30 pm
sana
Did Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - SANA
Low
Report
Did Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - SANA
11/7
11:00 am
sana
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA
11/5
09:43 am
sana
Sana Biotechnology, Inc. (NASDAQ: SANA) had its price target lowered by analysts at HC Wainwright from $11.00 to $8.00. They now have a "buy" rating on the stock.
High
Report
Sana Biotechnology, Inc. (NASDAQ: SANA) had its price target lowered by analysts at HC Wainwright from $11.00 to $8.00. They now have a "buy" rating on the stock.
11/5
07:00 am
sana
Sana Biotechnology, Inc. (NASDAQ: SANA) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
Medium
Report
Sana Biotechnology, Inc. (NASDAQ: SANA) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
11/4
04:45 pm
sana
Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 [Yahoo! Finance]
Medium
Report
Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 [Yahoo! Finance]
11/4
04:30 pm
sana
Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
High
Report
Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
10/18
10:26 am
sana
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Low
Report
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
9/30
04:05 pm
sana
Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
Low
Report
Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference